Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.

被引:0
|
作者
Broto, Javier Martin
Marcilla, David
Ramos, Rafael
Moura, David Silva
Alvarez, Ramiro
Hernandez, Nieves
Pujol, Carolina Agra
Mayordomo, Empar
Romagosa, Cleofe
Bague, Silvia
Reguero, Eugenia
Cruz, Julia
Martin, Francisco Javier
Gutierrez, Antonio
Cruz, Josefina
Alvarez, Rosa Maria Alvarez
Beveridge, Robert Diaz
Morales, Claudia Maria Valverde
Lopez-Pousa, Antonio
Martinez-Trufero, Javier
机构
关键词
D O I
10.1200/JCO.2017.35.15_suppl.11071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11071
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Xavier Garcia del Muro
    Enrique de Alava
    Vicenç Artigas
    Silvia Bague
    Alejandro Braña
    Ricardo Cubedo
    Josefina Cruz
    Nuria Mulet-Margalef
    Jose A. Narvaez
    Oscar Martinez Tirado
    Claudia Valverde
    Ramona Verges
    Joan Viñals
    Javier Martin-Broto
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 133 - 146
  • [22] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Garcia del Muro, Xavier
    de Alava, Enrique
    Artigas, Vicenc
    Bague, Silvia
    Brana, Alejandro
    Cubedo, Ricardo
    Cruz, Josefina
    Mulet-Margalef, Nuria
    Narvaez, Jose A.
    Martinez Tirado, Oscar
    Valverde, Claudia
    Verges, Ramona
    Vinals, Joan
    Martin-Broto, Javier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (01) : 133 - 146
  • [23] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Martin-Liberal, Juan
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Martin-Broto, Javier
    Cubedo, Ricardo
    Lavernia, Javier
    Redondo, Andres
    Antonio Lopez-Martin, Jose
    Mulet-Margalef, Nuria
    Sanjuan, Xavier
    Tirado, Oscar M.
    Garcia-del-Muro, Xavier
    TARGETED ONCOLOGY, 2018, 13 (01) : 81 - 87
  • [24] Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Buesa, JM
    Fra, J
    Anton, A
    Lopez-Pousa, A
    Martin, J
    del Muro, JG
    Escudero, P
    Casado, A
    Poveda, A
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 783 - 785
  • [25] Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
    Juan Martin-Liberal
    Antonio López-Pousa
    Javier Martínez-Trufero
    Javier Martín-Broto
    Ricardo Cubedo
    Javier Lavernia
    Andrés Redondo
    José Antonio López-Martín
    Nùria Mulet-Margalef
    Xavier Sanjuan
    Òscar M. Tirado
    Xavier Garcia-del-Muro
    Targeted Oncology, 2018, 13 : 81 - 87
  • [26] Prognostic value of EZH2 expression for immunotherapy-based schemes in advanced soft-tissue sarcoma: A translational research from Spanish Group of Research on Sarcoma (GEIS).
    Silva Moura, David
    Zamora, Jorge
    Hindi, Nadia
    Lopez-Alvarez, Maria
    Lacerenza, Serena
    Grignani, Giovanni
    Martinez-Trufero, Javier
    Redondo, Andres
    Maria Valverde Morales, Claudia
    Stacchiotti, Silvia
    Lopez-Pousa, Antonio
    Gutierrez, Antonio
    Lopez-Martin, Jose A.
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcoma
    Le Cesne, Axel
    Martin-Broto, Javier
    Grignani, Giovanni
    FUTURE ONCOLOGY, 2022, 18 (30S) : 5 - 11
  • [28] Analysis of expression of immunomodulation factors in alveolar soft-part sarcoma: a retrospective study from the Spanish Group for Research on Sarcoma (GEIS)
    Hindi, N.
    Fernandez-Serra, A.
    Martinez-Trufero, J.
    Carranza-Carranza, A.
    Lopez-Pousa, A.
    Lavernia, J.
    Arranz, J. L.
    Alegret, R. Lopez
    Martinez-Garcia, J.
    Morales, C. Valverde
    Cano, J. M.
    Vaz, M. A.
    Moura, D. S.
    Bague, S.
    Gonzalez-Campora, R.
    Lopez-Guerrero, J. A.
    Martin-Broto, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Exploratory analysis of prognostic factors for patients (pts) with advanced soft tissue sarcoma (ASTS) receiving combination chemotherapy: A joined study of the EORTC Soft Tissue and Bone Sarcoma Group and the French Sarcoma Group.
    Penel, N.
    Van Glabbeke, M. M.
    Nguyen, B. Bui
    Ouali, M.
    Mathoulin-Pelissier, S.
    Marreaud, S.
    Italiano, A.
    Brouste, V.
    Hogendoorn, P. C. W.
    Coindre, J.
    Blay, J.
    Hohenberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
    Gronchi, Alessandro
    Hindi, Nadia
    Cruz, Josefina
    Blay, Jean-Yves
    Lopez-Pousa, Antonio
    Italiano, Antoine
    Alvarez, Rosa
    Gutierrez, Antonio
    Rincon, Inmaculada
    Sangalli, Claudia
    Perez Aguiar, Jose Luis
    Romero, Jesus
    Morosi, Carlo
    Sunyach, Marie Pierre
    Sanfilippo, Roberta
    Romagosa, Cleofe
    Ranchere-Vince, Dominique
    Dei Tos, Angelo P.
    Casali, Paolo G.
    Martin-Broto, Javier
    ECLINICALMEDICINE, 2019, 9 : 35 - 43